Answers are grounded in this paper and cite their sources.
The synthesis and characterization of optically active phosphinooxazoline chloride complexes ( S M and R M )-[(η 6 - p -MeC 6 H 4 i Pr)MCl(PN)]A (M = Ru, Os; PN = phosphinooxazoline ligand; A = counteranion) and the derived aqua complexes ( R M and S M )-[(η 6 - p -MeC 6 H 4 i Pr)M(PN)(H 2 O)](A) 2 are reported. The OPOF 2 -containing compounds ( R M and S M )-[(η 6 - p -MeC 6 H 4 i Pr)M(OPOF 2 )(PN i Pr)][PF 6 ] (M = Ru, Os; PN i Pr = (4 S )-2-(2-diphenylphosphinophenyl)-4-isopropyl-1,3-oxazoline) have been also prepared and characterized. The molecular structures of ( S M )-[(η 6 - p -MeC 6 H 4 i Pr)MCl(PN i Pr)][SbF 6 ] (M = Ru, Os), ( S Ru )-[(η 6 - p -MeC 6 H 4 i Pr)RuCl(PNInd)][SbF 6 ] (PNInd = (3a S, 8a R )-2-(2-diphenylphosphinophenyl)-3a,8a-dihydroindane [1,2- d ]oxazole), and ( R Ru )-[(η 6 - p -MeC 6 H 4 i Pr)Ru(PN i Pr)(H 2 O)][SbF 6 ] and that of the OPOF 2 -containing compounds ( R Ru and S Ru )-[(η 6 - p -MeC 6 H 4 i Pr)Ru(OPOF 2 )(PN i Pr)][PF 6 ] have been determined by X-ray diffractometric methods. Dichloromethane solutions of the aqua complexes [(η 6 - p -MeC 6 H 4 i Pr)M(PN)(H 2 O)][SbF 6 ] 2 are active catalysts for the Diels−Alder reaction between methacrolein and cyclopentadiene. The reaction occurs rapidly at room temperature with good exo:endo selectivity (from 85:15 to 96:4) and moderate enantioselectivity (up to 47%). The intermediate Lewis acid−dienophile compound ( R Ru and S Ru )-[(η 6 - p -MeC 6 H 4 i Pr)Ru(PNInd)(methacrolein)][SbF 6 ] 2 was isolated, and the molecular structure of the S epimer was determined by diffractometric means. The osmium complexes ( S Os and R Os )- [(η 6 - p -MeC 6 H 4 i Pr)Os(PN)(H 2 O)][A] 2 (PN = PN i Pr, A = SbF 6, BF 4; PN = PNInd, A = SbF 6 ) evolve to the phenyl-containing compounds ( S Os and R Os )-[(η 6 - p -MeC 6 H 4 i Pr)OsPh(PN‘)][SbF 6 ] (PN‘ = (4 S )-2-(2-hydroxyphenylphosphinophenyl)-4-isopropyl-1,3-oxazoline (PNOH i Pr), PN‘ = (3a S, 8a R )-2-(2-hydroxyphenylphosphinophenyl)-3a,8a-dihydroindane[1,2 d ]oxazole] (PNOHInd)) and ( S Os and R Os )-[(η 6 - p -MeC 6 H 4 i Pr)OsPh(PNF i Pr)][BF 4 ] (PNF i Pr = (4 S )-2-(2-fluorophenylphosphinophenyl)-4-isopropyl-1,3-oxazoline), respectively, in which the phosphinooxazoline ligand incorporates a hydroxy or fluoro functionality. On the basis of spectroscopic and crystallographic observations, a common pathway for these reactions is proposed.
No takes yet. Share an insight, caveat, or question.
Carmona et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: